The global Intraoperative Neuromonitoring (IONM) Market, valued at USD 3.90 billion in 2023, is projected to reach USD 5.63 billion by 2030, growing at a CAGR of 5.4% from 2024 to 2030. IONM refers to the real-time monitoring of neural structures during surgical procedures to enhance patient safety and optimize surgical outcomes. The market encompasses devices, electrodes, software, and professional services provided to hospitals, surgical centers, and medical professionals. Growth is driven by the aging population, increasing prevalence of chronic diseases, and rising surgical volumes, particularly in neurosurgery, orthopedic, and cardiovascular procedures. Despite high initial investment costs acting as a restraint, innovations such as predictive analytics and AI-powered monitoring systems offer significant opportunities for market expansion. This manuscript provides a comprehensive analysis of market dynamics, segmentation, regional trends, and competitive strategies shaping the global IONM industry.